ABSTRACT
Clinical trials have established a framework to evaluate patient outcomes in the setting of standardized criteria for entry, treatment, and data analysis. The emphasis on clinical trials utilizing a prospective, randomized, multicentered design has centered, in its beginnings, on ophthalmic disease. The National Eye Institute’s focus on clinical trials evaluation of ophthalmic disease has set a standard for clinical trials throughout the National Institutes of Health and worldwide.
